Ultrasound localization of the ovaries for radiation-induced ovarian ablation

Clinical Oncology

Volumn 11, Issue 6, 1999, Pages 393-397

  Featherstone, C ^a   Harnett, A N ^a   Brunt, A M ^b  

^a BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^b University Hospital of Staffordshire   (United Kingdom)

Author keywords

Breast cancer; Ovarian ablation; Ultrasound

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; EARLY MENOPAUSE; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY; PELVIC GIRDLE; PRIORITY JOURNAL; PUBIS SYMPHYSIS; RADIATION DOSE; RADIOTHERAPY; SACROILIAC JOINT; SIMULATION; TREATMENT OUTCOME;

EID: 0033402287     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.1999.9090     Document Type: Article

References (16)

1. Beatson G T. On the treatment of inoperable cases of carcinoma of the mamma - suggestion for a new method of treatment with illustrative cases. Lancet. ii:1896;104-7,162-5.
2. NissenMeyer R. Primary breast cancer: the effect of primary ovarian irradiation. Ann Oncol. 2:1991;343-346.
3. Lancet. 348:1996;1189-1196.
4. Lancet. 339:1992;1-15,71- 85.
5. Boccardo F, Rubagotti A, Perrota A. Ovarian ablation versus goserelin with or without tamoxifen in preperimenopausal patients with advanced breast cancer: results of a multicentric Italian study. Ann Oncol. 5:1994;337-342.
6. Taylor C W, Green S, Dalton W S. Multicentre randomised clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptorpositive metastatic breast cancer: an intergroup study. J Clin Oncol. 16:1998;994-999.
7. Counsell R, Bain G, Williams M V. Artificial radiation menopause: where are the ovaries? Clin Oncol. 8:1996;250-253.
8. Cumins S M, Brunt A M. Does acupuncture influence the vasomotor symptoms experienced by breast cancer patients taking tamoxifen? P1D. 1997.
9. Campbell S, Goessens L, Goswamy R. Real-time ultrasonography for determination of ovarian morphology and volume. Lancet. 1:1982;Feb 20;425-426.
10. Leung S F, Tsao S Y, Teo P M. Ovarian ablation failures by radiation: a comparison of two dose schedules. Br J Radiol. 64:1991;537-538.
11. Reyno L, Levine M, Skingley P. Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancer. Eur J Cancer. 29A:1993;21-23.
12. Koyama H, Wada T, Nishiz Y. Cyclophosphamide induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer. 39:1977;1403-1409.
13. Padmanabhan N, Howell A, Rubens R D. Mechanism of action of adjuvant chemotherapy in early breast cancer. Lancet. 2:1996;Aug 23;411-414.
14. Bines J, Oleske D M, Cobleigh M A. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol. 14:1996;1718-1729.
15. Parulekar S. Ultrasound evaluation of the post-hysterectomy pelvis. J Clin Ultrasound. 10:1992;265-269.
16. Buy N, Ghossain M A, Sciot M D. Epithelial tumours of the ovary: CT findings and correlation with ultrasound. Radiology. 178:1991;811-818.